SECURITIES AND EXCHANGE COMMISSION
                               WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                        Commission File Number 000-32065

(Check One)

      [ ]     Form 10-K and Form 10KSB    [ ]    Form 11-K

      [ ]     Form 20-F   [X]    Form 10-Q and Form 10-QSB     [ ]   Form N-SAR

        For Period Ended:   August 31, 2001

      [ ]     Transition Report on Form 10-K and Form 10-KSB

      [ ]     Transition Report on Form 20-F

      [ ]     Transition Report on Form 11-K

      [ ]     Transition Report on Form 10Q and Form 10-QSB

      [ ]     Transition Report on Form N-SAR

        For Period Ended:

      Read Attached Instruction Sheet Before Preparing Form. Please Print or
Type.

      Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

      If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates.

                                     PART I

                            REGISTRATION INFORMATION

Full name of registrant: ConSyGen, Inc.

Former name if applicable: N/A

Address of principal executive office (Street and number): 125 South 52nd Street

City, state and zip code: Tempe, Arizona 85281

                                     PART II

                             RULE 12b-25(b) AND (c)

      If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12B-25(b), the
following should be completed. (Check box if appropriate.)

[ ] | (a)   The reasons described in reasonable detail in Part III of this form
    |       could not be eliminated without unreasonable effort or expense;
    |
[X] | (b)   The subject annual report, semi-annual report, transition report on
    |       Form 10-K, 10-KSB, 20-F, 11-K or Form N-SAR, or portion thereof will
    |       be filed on or before the 15th calendar day following the prescribed
    |       due date; or the subject quarterly report or transition report on
    |       Form 10-Q, 10-QSB, or portion thereof will be filed on or before the
    |       fifth calendar day following the prescribed due date; and
    |
[ ] | (c)   The accountant's statement or other exhibit required by Rule
    |       12b-25(c) has been attached if applicable.
    |
                                    PART III

                                    NARRATIVE

      State below in reasonable detail the reasons why Form 10-K, 10-KSB, 11-K,
20-F, 10-Q, 10-QSB, N-SAR or the transition report portion thereof could not be
filed within the prescribed time period. (Attach extra sheets if needed.)

      Registrant is in the process of completing its financial statements to be
included in the Form 10-KSB for the year ended May 31, 2001.

                                     PART IV

                                OTHER INFORMATION

(1)   Name and telephone number of person to contact in regard to this
      notification.

      Eric  J. Strasser                            (480) 394-9100
--------------------------------------------------------------------------------
         (Name)                            (Area Code) (Telephone Number)

(2)   Have all other periodic reports required under Section 13 or 15(d) or the
      Securities Exchange Act of 1934 or Section 30 of the Investment Company
      Act of 1940 during the preceding 12 months or for such period that the
      registrant was required to file such report(s) been filed? If the answer
      is no, identify report(s).

                                             Yes [ ]      No [X]

           Form 10KSB Dated May 31, 2001

(3)   Is it anticipated that any significant change in results of operations
      from the corresponding period for the last fiscal year will be reflected
      by the earnings statements to be included in the subject report or portion
      thereof?

                                             Yes [ ]      No [X]

      If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.

                                 ConSyGen, Inc.
--------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

      Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date:  October 15, 2001           By:      /s/ Eric J. Strasser
       ---------------              --------------------------------------------
                                      Eric J. Strasser, Chief Financial Officer